Tbio ATN1 Atrophin-1

Protein Summary

Description

Transcriptional corepressor. Recruits NR2E1 to repress transcription. Promotes vascular smooth cell (VSMC) migration and orientation (By similarity). Corepressor of MTG8 transcriptional repression. Has some intrinsic repression activity which is independent of the number of poly-Gln (polyQ) repeats. Dentatorubral pallidoluysian atrophy (DRPLA) is a rare neurodegenerative disorder characterized by cerebellar ataxia, myoclonic epilepsy, choreoathetosis, and dementia. The disorder is related to the expansion from 7-35 copies to 49-93 copies of a trinucleotide repeat (CAG/CAA) within this gene. The encoded protein includes a serine repeat and a region of alternating acidic and basic amino acids, as well as the variable glutamine repeat. Alternative splicing results in two transcripts variants that encode the same protein. [provided by RefSeq, Jul 2016]

Uniprot Accession IDs

• P54259
• Q99495
• Q99621
• Q9UEK7

Gene Name

• ATN1

Ensembl ID

• ENST00000356654
• ENSP00000349076
• ENSG00000111676
• ENST00000396684
• ENSP00000379915

Symbol

• D12S755E
• DRPLA
• B37
• HRS
• NOD
• DRPLA
• D12S755E

Knowledge Table

Most Knowledge About	Knowledge Value (0 to 1 scale)
transcription factor	0.86
hub protein	0.85
transcription factor binding site profile	0.76
cell line	0.72
kinase	0.69

Protein Classes

No PANTHER Classes or DTO Classes found

IDG Development Level Summary

Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 97.11   (req: < 5)

Gene RIFs: 30   (req: <= 3)

Antibodies: 135   (req: <= 50)

Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 97.11   (req: >= 5)

Gene RIFs: 30   (req: > 3)

Antibodies: 135   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 7

Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligand: 0

Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0